Name | Cvs Pharmacy #06032 |
---|---|
Organization Name | New Jersey Cvs Pharmacy Llc |
Location | 3560 Rte 27, Kendall Park, New Jersey 08824 |
Type | Durable Medical Equipment & Medical Supplies Supplier |
Phone | (732) 422-4334 |
Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
Several studies in the current issue of Topics of Spinal Cord Injury Rehabilitation put a needed spotlight on the health and health care disparities experienced by individuals with spinal cord injury. This research highlights the disparities in access for patients and lack of awareness about SCI by health care providers.
By 2017, the global electrophysiology mapping and ablation devices market is likely to achieve a value of $2.1 billion, according to a new report on companiesandmarkets.com. An ageing population, an increased number of diagnoses and several clinical studies have encouraged market growth.
New Jersey hospitals contributed $20.4 billion to the Garden State economy in 2012, according to the 2013 N.J. Hospitals Economic Impact Report released today by the New Jersey Hospital Association. This is the first time in the six years NJHA has published this report that the overall contribution from hospitals surpassed $20 billion.
Labopharm Inc. today announced the U.S. Food and Drug Administration (FDA) has approved OLEPTRO(TM) (trazodone hydrochloride) Extended Release Tablets, a novel once-daily formulation of the antidepressant trazodone, for the treatment of major depressive disorder (MDD) in adults. OLEPTRO(TM) utilizes CONTRAMID(R), Labopharm's clinically validated technology that controls the release of active substances within oral medications.
› Verified 8 days ago
NPI Number | 1104929926 |
Organization Name | NEW JERSEY CVS PHARMACY LLC |
Doing Business As | CVS PHARMACY #06032 |
Type | Durable Medical Equipment & Medical Supplies Supplier |
Address | 3560 Rte 27, Kendall Park, NJ 08824 |
Phone Number | 732-422-4336 |
News Archive
Several studies in the current issue of Topics of Spinal Cord Injury Rehabilitation put a needed spotlight on the health and health care disparities experienced by individuals with spinal cord injury. This research highlights the disparities in access for patients and lack of awareness about SCI by health care providers.
By 2017, the global electrophysiology mapping and ablation devices market is likely to achieve a value of $2.1 billion, according to a new report on companiesandmarkets.com. An ageing population, an increased number of diagnoses and several clinical studies have encouraged market growth.
New Jersey hospitals contributed $20.4 billion to the Garden State economy in 2012, according to the 2013 N.J. Hospitals Economic Impact Report released today by the New Jersey Hospital Association. This is the first time in the six years NJHA has published this report that the overall contribution from hospitals surpassed $20 billion.
Labopharm Inc. today announced the U.S. Food and Drug Administration (FDA) has approved OLEPTRO(TM) (trazodone hydrochloride) Extended Release Tablets, a novel once-daily formulation of the antidepressant trazodone, for the treatment of major depressive disorder (MDD) in adults. OLEPTRO(TM) utilizes CONTRAMID(R), Labopharm's clinically validated technology that controls the release of active substances within oral medications.
› Verified 8 days ago
News Archive
Several studies in the current issue of Topics of Spinal Cord Injury Rehabilitation put a needed spotlight on the health and health care disparities experienced by individuals with spinal cord injury. This research highlights the disparities in access for patients and lack of awareness about SCI by health care providers.
By 2017, the global electrophysiology mapping and ablation devices market is likely to achieve a value of $2.1 billion, according to a new report on companiesandmarkets.com. An ageing population, an increased number of diagnoses and several clinical studies have encouraged market growth.
New Jersey hospitals contributed $20.4 billion to the Garden State economy in 2012, according to the 2013 N.J. Hospitals Economic Impact Report released today by the New Jersey Hospital Association. This is the first time in the six years NJHA has published this report that the overall contribution from hospitals surpassed $20 billion.
Labopharm Inc. today announced the U.S. Food and Drug Administration (FDA) has approved OLEPTRO(TM) (trazodone hydrochloride) Extended Release Tablets, a novel once-daily formulation of the antidepressant trazodone, for the treatment of major depressive disorder (MDD) in adults. OLEPTRO(TM) utilizes CONTRAMID(R), Labopharm's clinically validated technology that controls the release of active substances within oral medications.
› Verified 8 days ago
Cvs Pharmacy #06032 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 3560 Rte 27, Kendall Park, New Jersey 08824 Phone: (732) 422-4334 |